Literature DB >> 27993956

Association of Kidney Function and Early Kidney Injury With Incident Hypertension in HIV-Infected Women.

Simon B Ascher1, Rebecca Scherzer1, Carmen A Peralta1, Phyllis C Tien1, Carl Grunfeld1, Michelle M Estrella1, Alison Abraham1, Deborah R Gustafson1, Marek Nowicki1, Anjali Sharma1, Mardge H Cohen1, Anthony W Butch1, Mary A Young1, Michael R Bennett1, Michael G Shlipak2.   

Abstract

Subclinical kidney disease is associated with developing hypertension in the general population, but data are lacking among HIV-infected people. We examined associations of kidney function and injury with incident hypertension in 823 HIV-infected and 267 HIV-uninfected women in the Women's Interagency HIV Study, a multicenter, prospective cohort of HIV-infected and uninfected women in the United States. Baseline kidney biomarkers included estimated glomerular filtration rate using cystatin C, urine albumin-to-creatinine ratio, and 7 urine biomarkers of tubular injury: α-1-microglobulin, interleukin-18, kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, liver fatty acid-binding protein, N-acetyl-β-d-glucosaminidase, and α1-acid-glycoprotein. We used multivariable Poisson regression to evaluate associations of kidney biomarkers with incident hypertension, defined as 2 consecutive visits of antihypertensive medication use. During a median follow-up of 9.6 years, 288 HIV-infected women (35%) developed hypertension. Among the HIV-infected women, higher urine albumin-to-creatinine ratio was independently associated with incident hypertension (relative risk =1.13 per urine albumin-to-creatinine ratio doubling, 95% confidence interval, 1.07-1.20), as was lower estimated glomerular filtration rate (relative risk =1.10 per 10 mL/min/1.73 m2 lower estimated glomerular filtration rate; 95% confidence interval, 1.04-1.17). No tubular injury and dysfunction biomarkers were independently associated with incident hypertension in HIV-infected women. In contrast, among the HIV-uninfected women, urine albumin-to-creatinine ratio was not associated with incident hypertension, whereas higher urine interleukin-18, α1-acid-glycoprotein, and N-acetyl-β-d-glucosaminidase levels were significantly associated with incident hypertension. These findings suggest that early glomerular injury and kidney dysfunction may be involved in the pathogenesis of hypertension in HIV-infected people. The associations of tubular markers with hypertension in HIV-uninfected women should be validated in other studies.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  HIV; albuminuria; glomerular filtration rate; hypertension; kidney disease

Mesh:

Substances:

Year:  2016        PMID: 27993956      PMCID: PMC5233560          DOI: 10.1161/HYPERTENSIONAHA.116.08258

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  45 in total

1.  Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients.

Authors:  S K Gupta; B W Mamlin; C S Johnson; M D Dollins; J M Topf; M P Dubé
Journal:  Clin Nephrol       Date:  2004-01       Impact factor: 0.975

2.  Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension.

Authors:  A C Guyton; T G Coleman; A V Cowley; K W Scheel; R D Manning; R A Norman
Journal:  Am J Med       Date:  1972-05       Impact factor: 4.965

3.  Hypertension in HIV-infected patients: prevalence and related factors.

Authors:  Carlos Jericó; Hernando Knobel; Milagro Montero; María L Sorli; Ana Guelar; Juan L Gimeno; Pere Saballs; Jose L López-Colomés; Juan Pedro-Botet
Journal:  Am J Hypertens       Date:  2005-11       Impact factor: 2.689

4.  Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy.

Authors:  Heidi M Crane; Stephen E Van Rompaey; Mari M Kitahata
Journal:  AIDS       Date:  2006-04-24       Impact factor: 4.177

Review 5.  Albuminuria reflects widespread vascular damage. The Steno hypothesis.

Authors:  T Deckert; B Feldt-Rasmussen; K Borch-Johnsen; T Jensen; A Kofoed-Enevoldsen
Journal:  Diabetologia       Date:  1989-04       Impact factor: 10.122

6.  C-reactive protein and the risk of developing hypertension.

Authors:  Howard D Sesso; Julie E Buring; Nader Rifai; Gavin J Blake; J Michael Gaziano; Paul M Ridker
Journal:  JAMA       Date:  2003-12-10       Impact factor: 56.272

7.  Chronic kidney disease in HIV infection: an urban epidemic.

Authors:  Christina M Wyatt; Jonathan A Winston; Carlos D Malvestutto; Dawn A Fishbein; Irina Barash; Alan J Cohen; Mary E Klotman; Paul E Klotman
Journal:  AIDS       Date:  2007-10-01       Impact factor: 4.177

8.  Correlates of hypertension in patients with AIDS in the era of highly active antiretroviral therapy.

Authors:  Katherine Krauskopf; Mark L Van Natta; Ronald P Danis; Sapna Gangaputra; Lori Ackatz; Adrienne Addessi; Alex D Federman; Andrea D Branch; Curtis L Meinert; Douglas A Jabs
Journal:  J Int Assoc Provid AIDS Care       Date:  2013 Sep-Oct

9.  Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome.

Authors:  Carmine Gazzaruso; Raffaele Bruno; Adriana Garzaniti; Stefano Giordanetti; Pietro Fratino; Paolo Sacchi; Gaetano Filice
Journal:  J Hypertens       Date:  2003-07       Impact factor: 4.844

Review 10.  Immunologic basis of cardiovascular disease in HIV-infected adults.

Authors:  Priscilla Y Hsue; Steven G Deeks; Peter W Hunt
Journal:  J Infect Dis       Date:  2012-06       Impact factor: 5.226

View more
  4 in total

Review 1.  Hypertension in HIV-Infected Adults: Novel Pathophysiologic Mechanisms.

Authors:  Sasha A Fahme; Gerald S Bloomfield; Robert Peck
Journal:  Hypertension       Date:  2018-05-18       Impact factor: 10.190

2.  Acute Kidney Injury Biomarkers Predict an Increase in Serum Milrinone Concentration Earlier Than Serum Creatinine-Defined Acute Kidney Injury in Infants After Cardiac Surgery.

Authors:  Katja M Gist; David S Cooper; Julia Wrona; Sarah Faubel; Christopher Altmann; Zhiqian Gao; Bradley S Marino; Jeffrey Alten; Kristal M Hock; Tomoyuki Mizuno; Alexander A Vinks; Melanie S Joy; Michael F Wempe; Michael R Bennett; Stuart L Goldstein
Journal:  Ther Drug Monit       Date:  2018-04       Impact factor: 3.681

3.  Hypertension in HIV-Infected Patients Receiving Antiretroviral Therapy in Northeast Ethiopia.

Authors:  Temesgen Fiseha; Alemu Gedefie Belete; Henok Dereje; Abebe Dires
Journal:  Int J Hypertens       Date:  2019-12-23       Impact factor: 2.420

4.  Risk Factors Attributable to Hypertension among HIV-Infected Patients on Antiretroviral Therapy in Selected Rural Districts of the Eastern Cape Province, South Africa.

Authors:  Urgent Tsuro; Kelechi E Oladimeji; Guillermo-Alfredo Pulido-Estrada; Teke R Apalata
Journal:  Int J Environ Res Public Health       Date:  2022-09-06       Impact factor: 4.614

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.